The present work is evidence based but has permitted integration of BC experts’ views, mainly radiation oncologists but also a BC surgeon and a medical oncologist, all around Switzerland, reflecting modern clinical care in radiation oncology in the BC setting in the country....
Oncologist 21, 771–777, https://doi.org/10.1634/theoncologist.2015-0445 (2016). Article PubMed PubMed Central Google Scholar Download references Acknowledgements This work was supported by grants from the Ministry of Health and Welfare, Taiwan (MOHW108-TDU-B-212-133004), China Medical ...
white, and non-scrapable lesion that appears to be “a predominantly white plaque of questionable risk having excluded (other) known diseases or disorders that carry no increased risk for cancer”.24,25,26,27OL patients have a prospective risk of malignancy ranging between 1% and 30%.28OL co...
the stroma can be considered tumor suppressive [6]. However, the tumor stroma is constantly changing rather than a static entity, and our researches mainly focus on the roles and mechanisms by which stromal elements accelerate cancer initiation and progression, aiming at providing theoretical rationale...
The target audience includes endocrinologists, radiologists, thyroid surgeons, and oncologists. Therefore, a multidisciplinary panel was convened to develop this clinical review. Methods The American Association of Clinical Endocrinology Clinical Practice Guidelines Oversight Committee identified the necessity of...
5.3.2. Patient/oncologist related challenges Other factors such as the patient’s age, patient’s comorbid condition, patient’s adherence, oncologist’s experience, and oncologist’s preferences may prove to be challenging for the oral administration of anticancer drugs [14,216,217]. Aging can ...
Accurate prognosis, or determination of distant metastasis-free survival could allow the oncologist to tailor the administration of adjuvant chemotherapy, with women having poorer prognoses being given the most aggressive treatment. Furthermore, accurate prediction of poor prognosis would greatly impact ...
Oncologist 17, 72–79 (2012). Article CAS PubMed Google Scholar Boscoe, A. N., Rolland, C. & Kelley, R. K. Frequency and prognostic significance of isocitrate dehydrogenase 1 mutations in cholangiocarcinoma: a systematic literature review. J. Gastrointest. Oncol. 10, 751–765 (2019). ...
Oncologist 18, 314–322 (2013). Article CAS PubMed PubMed Central Google Scholar Elkins, J. M. et al. Comprehensive characterization of the published kinase inhibitor set. Nat. Biotechnol. 34, 95–103 (2015). Article PubMed CAS Google Scholar van Vliet, D. et al. Infants with ...
Osteosarcoma, with poor survival after metastasis, is considered the most common primary bone cancer in adolescents. Notwithstanding the efforts of researchers, its five-year survival rate has only shown limited improvement, suggesting that existing ther